RENAL OUTCOMES IN DIABETIC KIDNEY PATIENTS TREATED WITH GLP1 AGONIST RECEPTORS VS SGLT2 INHIBITORS

被引:0
|
作者
Maroto, Alba [1 ]
Vidas, Maria Marques [1 ]
Sanz, Ignacio [1 ]
Lopez, Paula [1 ]
Portoles, Jose' M. [1 ]
机构
[1] Hosp Univ Puerta Hierro Majadahonda Madrid, Nephrol, Majadahonda, Spain
关键词
D O I
暂无
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
P1009
引用
下载
收藏
页码:1331 / 1331
页数:1
相关论文
共 50 条
  • [1] Renal outcomes of SGLT2 inhibitors and GLP1 agonists in clinical practice
    Annemarie B. van der Aart-van der Beek
    Hiddo J. L. Heerspink
    Nature Reviews Nephrology, 2020, 16 : 433 - 434
  • [2] Influence of Blood Pressure Management on the Renal Outcome in Patients Treated with SGLT2 Inhibitors and GLP1 Receptor Agonist
    Kobayashi, Kazuo
    Toyoda, Masao
    Kawanami, Daiji
    Tamura, Kouichi
    DIABETES, 2024, 73
  • [3] Renal outcomes of SGLT2 inhibitors and GLP1 agonists in clinical practice
    van der Aart-van der Beek, Annemarie B.
    Heerspink, Hiddo J. L.
    NATURE REVIEWS NEPHROLOGY, 2020, 16 (08) : 433 - 434
  • [4] SGLT2 INHIBITORS VS. GLP1 AGONISTS AS TREATMENTS FOR OSTEOARTHRITIS
    Jafarzadeh, S. Reza
    Ma, Kevin
    Peloquin, Christine E.
    Felson, David
    OSTEOARTHRITIS AND CARTILAGE, 2024, 32 : S41 - S42
  • [5] Outcomes of SGLT2 Inhibitors Use in Diabetic Renal Transplant Patients
    AlKindi, Fatima
    Al-Omary, Hanan L.
    Hussain, Qutaiba
    Al Hakim, Mohamed
    Chaaban, Ahmed
    Boobes, Yousef
    TRANSPLANTATION PROCEEDINGS, 2020, 52 (01) : 175 - 178
  • [6] Mechanistic insights regarding the role of SGLT2 inhibitors and GLP1 agonist drugs on cardiovascular disease in diabetes
    Garg, Vinay
    Verma, Subodh
    Connelly, Kim
    PROGRESS IN CARDIOVASCULAR DISEASES, 2019, 62 (04) : 349 - 357
  • [7] Differential cardiovascular and renal benefits of SGLT2 inhibitors and GLP1 receptor agonists in patients with type 2 diabetes mellitus
    Kim, Chee Hae
    Hwang, In-Chang
    Choi, Hong-Mi
    Ahn, Chang Ho
    Yoon, Yeonyee E.
    Cho, Goo-Yeong
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2022, 364 : 104 - 111
  • [8] GLP1 receptor agonist overcomes SGLT2 inhibitor-related overeating
    Matthias Blüher
    Nature Reviews Endocrinology, 2022, 18 : 523 - 524
  • [9] GLP1 receptor agonist overcomes SGLT2 inhibitor-related overeating
    Blueher, Matthias
    NATURE REVIEWS ENDOCRINOLOGY, 2022, 18 (09) : 523 - 524
  • [10] Diabetic Agents, From Metformin to SGLT2 Inhibitors and GLP1 Receptor Agonists JACC Focus Seminar
    Wilcox, Tanya
    De Block, Christophe
    Schwartzbard, Arthur Z.
    Newman, Jonathan D.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (16) : 1956 - 1974